St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)
Start Date
6/27/2022
Completion Date
12/31/2032
Summary
The SPARC-C study is a prospective, multi-institutional observational study of patients referred for the management of large (≥ 20mm) non-pedunculated colorectal polyps (LNPCPs). Patients are managed consistent with current standards of care. Prospectively collected data includes: patient clinicodemographic details, lesion details, procedural details, and clinical outcomes.
Detailed Description
Endoscopic resection techniques, including endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and cold snare resection (CSR), have become the primary treatment strategy for the vast majority of large non-pedunculated colorectal polyps (LNPCPs). This is because of the efficacy, safety, and cost-effectiveness of endoscopic techniques compared to surgery. Site-specific technical modifications and the development of auxiliary techniques/strategies have mitigated the risk of technical failure, clinically significant post-resection bleeding (CSPEB), significant deep mural injury (S-DMI)/perforation, and recurrence. However, questions still remain about the application and selection of these techniques. This is a prospective, multicentre cohort study of consecutive patients referred to an interventional endoscopist with a tertiary referral practice in minimally invasive endoscopic resection techniques for the management of a LNPCP. This study will be based at St. Paul's Hospital (and its affiliated sites), Vancouver General Hospital, and collaborating sites, with the aim of enrolling 3500 participants over 10 years. This cohort serves as a platform to continue refining the management of LNPCPs. We will evaluate LNPCP management outcomes, including technical success, clinical success, clinically significant intra-procedural bleeding (CSIPB), S-DMI, CSPEB, delayed perforation, recurrence, and referral to surgery. Findings will also help to further refine mitigating strategies for intra-procedural and post-procedural adverse outcomes (CSPIB, S-DMI, CSPEB, delayed perforation, recurrence, and referral to surgery). Finally, we aim to optimize the application of minimally invasive endoscopic resection techniques for the management of LNPCPs, including the development of artificial intelligence clinical decision support solutions (AI-CDSS).
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Endoscopic tissue resection
Conditions
Locations
St. Cloud Hospital
Saint Cloud, Minnesota 56303
United States
Mount Saint Joseph Hospital
Vancouver, British Columbia V5T 3N4
Canada
Vancouver General Hospital
Vancouver, British Columbia V6B2W6
Canada
St. Paul's Hospital
Vancouver, British Columbia V6Z 1Y6
Canada
Pacific Gastroenterology Associates
Vancouver, British Columbia V6Z 2K5
Canada
Hadassah Ein Kerem Hospital
Jerusalem,
Israel